Priority dates, work visas, and labor market data
H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
National AverageGrowth
Growth 2008-2019 (Filing Volume)Top Employers
Hiring This Role| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| AMGEN INC. | 31 | $163,431 | $84,760 - $303,850 | 96.8% |
| GILEAD SCIENCES, INC. | 21 | $136,588 | $113,147 - $239,658 | 100.0% |
| PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC | 17 | $89,908 | $63,123 - $132,558 | 94.1% |
| GENENTECH | 16 | $171,674 | $90,000 - $292,128 | 100.0% |
| NOVARTIS PHARMACEUTICALS CORPORATION | 14 | $182,111 | $93,732 - $282,000 | 85.7% |
| PPD DEVELOPMENT, LP | 9 | $100,245 | $86,926 - $119,213 | 100.0% |
| PAREXEL INTERNATIONAL | 8 | $106,503 | $92,000 - $115,000 | 100.0% |
| BRISTOL MYERS SQUIBB COMPANY | 7 | $185,316 | $145,517 - $247,450 | 100.0% |
| ION GEOPHYSICAL CORPORATION | 7 | $130,765 | $120,619 - $157,061 | 85.7% |
| VERTEX PHARMACEUTICALS INCORPORATED | 7 | $156,507 | $105,000 - $223,000 | 100.0% |
| BAYER HEALTHCARE PHARMACEUTICALS | 6 | $233,676 | $211,245 - $248,745 | 100.0% |
| CAPITAL ONE SERVICES, INC. | 6 | $139,100 | $120,000 - $160,000 | 100.0% |
| QUINTILES, INC. | 5 | $131,835 | $85,541 - $168,759 | 80.0% |
| MERCK SHARP & DOHME CORP | 5 | $189,975 | $128,981 - $236,434 | 60.0% |
| ABBOTT LABORATORIES | 5 | $119,930 | $80,000 - $140,000 | 100.0% |
| City | State | Filings | Median Salary |
|---|---|---|---|
| THOUSAND OAKS | CA | 29 | $161,254 |
| WILMINGTON | NC | 26 | $96,296 |
| NEW YORK | NY | 23 | $142,294 |
| HOUSTON | TX | 20 | $137,881 |
| FOSTER CITY | CA | 20 | $133,404 |
| SOUTH SAN FRANCISCO | CA | 16 | $174,696 |
| CAMBRIDGE | MA | 14 | $156,171 |
| Houston | TX | 13 | $161,988 |
| WALTHAM | MA | 12 | $124,410 |
| BOSTON | MA | 11 | $140,099 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| FY 2008 | 24 | $113,979 | 95.8% |
| FY 2010 | 54 | $131,340 | 94.4% |
| FY 2011 | 28 | $120,601 | 100.0% |
| FY 2012 | 32 | $130,010 | 96.9% |
| FY 2013 | 45 | $148,043 | 86.7% |
| FY 2014 | 93 | $129,869 | 96.8% |
| FY 2015 | 80 | $133,045 | 93.8% |
| FY 2016 | 123 | $134,220 | 95.1% |
| FY 2017 | 110 | $133,169 | 93.6% |
| FY 2018 | 146 | $122,502 | 97.9% |
| FY 2019 | 116 | $132,003 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| AMGEN INC. | 31 | $163,431 | 96.8% |
| GILEAD SCIENCES, INC. | 21 | $136,588 | 100.0% |
| PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC | 17 | $89,908 | 94.1% |
| GENENTECH | 16 | $171,674 | 100.0% |
| NOVARTIS PHARMACEUTICALS CORPORATION | 14 | $182,111 | 85.7% |